Article
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305.
Breast cancer research and treatment - 1 Jan 2010
Giordano Cinzia, Cui Yukun, Barone Ines, Ando Sebastiano, Mancini Michael A, Berno Valeria, Fuqua Suzanne A W
Abstract excerpt
Estrogens play a crucial role in breast tumor growth, which is the rationale for the use of antiestrogens, such as tamoxifen, in women with estrogen receptor (ER)-alpha-positive breast cancer. However, hormone resistance is a major clinical problem. Altered growth factor signaling to the ERalpha...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
